Response Genetics, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch RGDXQ and buy or sell other stocks, ETFs, and their options commission-free!

About RGDXQ

Response Genetics, Inc. is engaged in the research and development of clinical diagnostic tests for cancer. Its platforms include analysis of single biomarkers using the polymerase chain reaction method as well as global gene interrogation using microarray methods from paraffin or frozen tissue specimens. 

CEO
Thomas A. Bologna, MBA
CEOThomas A. Bologna, MBA
Employees
100
Employees100
Headquarters
Los Angeles, California
HeadquartersLos Angeles, California
Founded
1999
Founded1999
Employees
100
Employees100

RGDXQ Key Statistics

Market cap
3.88K
Market cap3.88K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
388.89
Average volume388.89
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.00
52 Week high$0.00
52 Week low
$0.00
52 Week low$0.00
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.